Fusion Antibodies : Results of voting at Annual General Meeting on 23 September 2022 (pdf)

Fusion Antibodies plc

Results of voting at Annual General Meeting on 23 September 2022

All resolution proposed at the AGM were passed on a poll. The results of the voting are set out below. Any votes that were for the discretion of the Chair have been included in the votes 'for'.

				Percentage of votes cast
Resolution	Outcome	Votes cast	For	Against
Ordinary Resolutions
1.	To receive the Company's annual
	accounts and the strategic,	Passed	7,800,587	99.99%	0.01%
	directors' and auditor's reports
	for the year ended 31 March
	2022
2.	To reappoint Adrian Kinkaid,
	who retires in accordance with	Passed	8,576,156	99.99%	0.01%
	the Articles of Association, as a
	director
3.	To reappoint Matthew Baker,
	who retires by rotation, as a	Passed	8,576,156	99.42%	0.58%
	director
4.	To reappoint Simon Douglas,
	who retires by rotation, as a	Passed	8,576,156	96.30%	3.70%
	director
5.	To reappoint Richard Buick, who
	retires by rotation, as a director	Passed	8,576,156	96.30%	3.70%
6.	To reappoint
	PricewaterhouseCoopers LLP as	Passed	8,323,181	99.75%	0.25%
	auditors
7.	To authorise the Audit
	Committee to determine the	Passed	8,576,156	99.99%	0.01%
	remuneration of the auditors
8.	To authorise the directors to
	allot relevant securities of up to	Passed	8,576,156	99.99%	0.01%
	a nominal value of £346,865.92,
	subject to certain conditions
Special Resolutions
9.	To empower the directors to
	allot relevant securities of up to	Passed	8,530,531	99.22%	0.78%
	a nominal value of £104,059.76
	on a non-pre-emptive basis
	subject to certain conditions
10.To authorise the Company to
	make market purchases of up to	Passed	7,046,097	99.09%	0.91%
	2,601,494 ordinary shares
	subject to certain conditions